Grants and Contributions:
Title:
Development of an ocular oximetry device for the clinical market
Agreement Number:
939804
Agreement Value:
$720,750.00
Agreement Date:
Dec 2, 2019 - Feb 25, 2022
Description:
Product development and adapting it to the clinical market. Two main objectives: to increase the accuracy of the measurements taken by the device and to develop the diagnostic capabilities of the device.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Quebec, Quebec, CA G1K 3G5
Reference Number:
172-2019-2020-Q4-939804
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
819510900
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 119 days. The total amended value is 225,000 dollars.
Amendment Date
Aug 24, 2021
Recipient's Legal Name:
Zilia inc.
Federal Riding Name:
Québec
Federal Riding Number:
24059
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
334512
Amendments: